Skip to Content
415-441-8669 | TOLL FREE: 888-50EVANS

PHONE: 415-441-8669 | TOLL FREE: 888-50EVANS

Tag: Drug Marketing

Jul 22, 2013 - Blog by |

Pharmaceutical Manufacturer Agrees to Settle Whistleblower Lawsuit for $500 Million

ATTORNEY NEWSLETTER A large Indian pharmaceutical manufacturer has agreed to settle with the United States and states’ attorneys general in a whistleblower lawsuit.  The pharmaceutical manufacturer was alleged to have falsified data, violated Current Good Manufacturing and Laboratory Practices, and sold substandard and unapproved drugs.  This settlement happened due of […]

Jul 8, 2013 - Blog by |

Whistleblowers are helping to clean up pharmaceutical manufacturing facilities

ATTORNEY NEWSLETTER In the past, the Food and Drug Administration (FDA) took the lead role in investigating pharmaceutical manufacturing facilities for violations of good manufacturing practices (cGMP’s).  Recently, the Department of Justice (DOJ) became a more actively involved in enforcement actions against pharmaceutical manufacturing facilities due to whistleblowers.  The DOJ […]

Apr 24, 2013 - Blog by |

Fresenius Medical Care’s Acid Concentrates Causes High Cardiac Risk on Dialysis Patients

– ATTORNEY NEWSLETTER –  The Food and Drug Administration recalled two powerful acid concentrates in March of 2012. Both products, GranuFlo, a powder-based concentrate, and Naturalyte, a liquid-based concentrate, were sold to numerous dialysis centers nationwide. Medical directors and physicals anonymously reported “troubling findings” associated with both concentrates’ dosing measurements […]

Jul 6, 2012 - Blog by |

GlaxoSmithKline To Pay $3 Billion Settlement

Monday, July 02, 2012. After a lengthy investigation and indictment, GlaxoSmithKline(GSK) has reached a plea agreement with the U.S. government and will pay $3 billion to settle one of the most significant health-care fraud cases in history. GlaxoSmithKline was charged with counts in violation of the United States Federal Food, […]

May 3, 2012 - Blog by |

McKesson Settlement for $190 Million Under False Claims Act

McKesson Settlement for $190 Million Under False Claims Act McKesson corporation, a San Francisco-based company and one of the largest pharmaceuticals companies in the world, will pay $190  million as settlement in a whistleblower case under the False Claims Act. Whistleblower David Morgan is a Pennsylvania pharmacist and healthcare auditor […]

Feb 15, 2012 - Blog by |

Dava Pharmaceuticals Whistleblower Case Settles for $11 Million

Dava Pharmaceuticals Whistleblower Case Settles for $11 Million PRWeb Dava Pharmaceuticals, Inc., has agreed to an $11 million settlement in response to allegations of healthcare fraud. The allegations relate to a false misclassification of certain drugs: Cefdinir, Clarithromycin, and Methotrexate. The alleged misclassification of these drugs as “non-innovator” drugs as […]

Jan 23, 2012 - Blog by |

Actavis settles Medicaid fraud case for $84 million

 Actavis settles Medicaid fraud case for $84 million Reuters [Article submitted by Dr. Caroline Poplin] Actavis Group, a privately held generic pharmaceutical company based in Iceland, has settled a Medicaid fraud case for $84 million with the state of Texas. According to Texas Attorney General Greg Abbott, Actavis had been […]

Law Dragons 500 badge Million Dollar Advocates Forum SuperLawyers Badge Best Lawyers Badge Avvo

Our Passion For Justice

415-441-8669 888-50EVANS

Hear What Our Clients Have To Say

"I contacted Attorney Ingrid Evans for advice about a financial elder abuse case. She was extremely knowledgeable, bright and informative. I highly recommend her. I am an attorney myself, and know when I am talking to a another excellent attorney."
Posted By: Terry Kolkey Attorney

Read More Reviews